Brainstorm Cell Therapeutics Inc. (BCLI.OB) Elects Malcolm Taub to its Board of Directors
Source: http://Blog.QualityStocks.net/?p=14764Posted on Monday, March 23rd, 2009 | In Small & Micro Cap
Brainstorm Cell Therapeutics Inc. today announced the election of Malcolm S. Taub to its Board of Directors. Malcolm Taub has had a distinguished career in the practice of law in New York City for 34 years. He has had a varied practice ranging from complex Federal Securities matters, fraud litigation to real estate litigation. He has been a leader in Latin American securities matters and has served as a consultant to the Argentinean Stock Exchange. His investment firm provided consultation, as well as advice with respect to bringing foreign private entities public in the United States.
Mr. Taub has been teaching law at several colleges and universities, including the New York University Real Estate Institute, Long Island University and Marymount College. He is presently a Trustee of The Gateway Schools of New York; which is devoted to educating learning disabled children, as well as the Devereux Glenholme School in Washington, Connecticut.
When asked about the effect of the election of Taub, Brainstorm President Chaim Lebovits said, “We are proud to have Mr. Taub join the Brainstorm team. His extensive legal, financial and business background will, with G-d’s help, immensely contribute toward helping us to achieve our goals of further growth and success of the Company and its cause.”
This appointment increases Brainstorm’s board of five members. In addition to Mr. Taub, the members of Brainstorm’s board include Dr. Irit Arbel, one of the founders of Brainstorm who served as its president until November 2004; Dr. Jonathan Javitt, who is also a Former White House Advisor; John Hopkins Professor; and Mr. Moshe Lion, a senior partner of Lion, Orlitzky and Co., a member of Moore Stephens International, who also served as Director General of the Israel Prime Minister’s Office, as well as an economic advisor to the Israel Prime Minister. The company’s previous plans to appoint Ambassador Daniel Ayalon to the board were changed of necessity when he was elected to the Israeli Knesset.
Let us hear your thoughts below:
Last 5 posts by QualityStocks
- Novavax, Inc. (NVAX) Prices Offering Of Common Stock - November 24th, 2009
- Freshwater Technologies (FWTC.OB) Water Activation Technology Increases the Germination of Vegetable Crops - November 24th, 2009
- AlumniFuel Power Corp. (AFPW.OB) Subsidiary Turns Heads with Technology at Naval Energy Forum - November 24th, 2009
- Provectus Pharmaceuticals Inc. (PVCT.OB) Delivers Favorable Oncology Treatment; Presents Data to 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers - November 24th, 2009
- TapImmune, Inc. (TPIV.OB) Among the Winners in the Booming Vaccine Business - November 24th, 2009
Argentinean Stock Exchange;, Brainstorm Cell Therapeutics Inc.;, Chaim Lebovits;, Connecticut, Daniel Ayalon;, Devereux Glenholme School;, Irit Arbel;, israel, Israel Prime Minister's Office;, Israeli Knesset, Jonathan Javitt;, Long Island University;, Malcolm S. Taub;, Malcolm Taub;, Marymount College;, Moore Stephens International;, Moshe Lion;, New York, New York City, New York University Real Estate Institute;, Orlitzky and Co.;, real estate litigation;, Small & Micro Cap, United States, Washington, White House
![]() About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |



